Cannabis capital markets have faced significant challenges over the past few years. As investors who have been actively involved in the industry since 2019, we have had the privilege of experiencing every market cycle – from euphoric highs to sobering lows.
Despite these fluctuations, today’s market environment presents an unparalleled opportunity for discerning investors, thanks to unique deal structures, compelling valuations and the ability to identify and back exceptional management teams.
The marijuana industry’s struggles with access to capital have fundamentally reshaped the competitive landscape. Over the past two years, funding sources have dried up, leaving many companies to adapt or face extinction.
This environment has proved to be a litmus test for management teams. Companies that relied on continuous funding to mask operational inefficiencies are no longer able to do so.
This article was originally published on MJBizDaily, read the rest here.
Could 2025 Be a Bumper Year for Cannabis Capital Markets?
Cannabis capital markets have faced significant challenges over the past few years. As investors who have been actively involved in the industry since 2019, we have had the privilege of experiencing every market cycle – from euphoric highs to sobering lows.
Despite these fluctuations, today’s market environment presents an unparalleled opportunity for discerning investors, thanks to unique deal structures, compelling valuations and the ability to identify and back exceptional management teams.
The marijuana industry’s struggles with access to capital have fundamentally reshaped the competitive landscape. Over the past two years, funding sources have dried up, leaving many companies to adapt or face extinction.
This environment has proved to be a litmus test for management teams. Companies that relied on continuous funding to mask operational inefficiencies are no longer able to do so.
This article was originally published on MJBizDaily, read the rest here.
Australia’s Medical Cannabis Market Set to Outgrow Europe’s Biggest Players
Next PostCRS Research Says Cannabis Rescheduling Future ‘Unclear’ as Legal Challenges Emerge
MJBizDaily
Related Posts
Related Posts
Trump’s DEA Revolving Door: 4th Administrator in as Many Months Rings Alarm Bells for Cannabis Industry
The fourth head of the Drug Enforcement Administration (DEA) in as many months has been given the green light by...
Republican Senators Introduce Bill to Block Cannabis 280E Tax Relief Even if Cannabis Is Rescheduled
As the cannabis rescheduling project hangs in the balance, two Republican senators are attempting to ensure that one of its...
The UK Risks Missing Out on the Next $1 Billion Cannabinoid Opportunity
Arizona Attempts to Force Funding of Medical Cannabis Research Through Sales Taxes
Hawaii House Shelves Recreational Cannabis Bill in Stunning Reversal
New York Bill Seeks to Decriminalize Drug Possession, Establish Reform Task Force
CONNECT
Related Posts
Related Posts
Trump’s DEA Revolving Door: 4th Administrator in as Many Months Rings Alarm Bells for Cannabis Industry
The fourth head of the Drug Enforcement Administration (DEA) in as many months has been given the green light by...
Republican Senators Introduce Bill to Block Cannabis 280E Tax Relief Even if Cannabis Is Rescheduled
As the cannabis rescheduling project hangs in the balance, two Republican senators are attempting to ensure that one of its...
The UK Risks Missing Out on the Next $1 Billion Cannabinoid Opportunity
A groundbreaking achievement is flying under the radar. Epidiolex, the first FDA approved cannabis-derived drug developed by GW Pharmaceuticals, is...
Arizona Attempts to Force Funding of Medical Cannabis Research Through Sales Taxes
Arizona lawmakers are attempting to force the state’s Department of Health Services (DHS) to put millions of dollars towards medical...
Hawaii House Shelves Recreational Cannabis Bill in Stunning Reversal
Less than 48 hours after Hawaii lawmakers appeared poised to legalize recreational cannabis, the state’s House of Representatives unexpectedly slammed...
Recent Posts
Related Posts
Republican Senators Introduce Bill to Block Cannabis 280E Tax Relief Even if Cannabis Is Rescheduled
As the cannabis rescheduling project hangs in the balance, two Republican senators are attempting to ensure that one of its...
Damning Colorado Cannabis Test Shows Vast Majority of Products Do Not Comply With Regulations
More than 85% of regulated cannabis products sold in Colorado’s adult-use market might violate health and labeling laws, according to...
Oregon’s Oversupply Issues Reach Breaking Point as Prices Reach All-Time Low
Oregon’s cannabis industry is in crisis as a record-breaking harvest in 2024 exacerbates an already severe oversupply problem.
Difficult Start to the Year for Cannabis Stocks as Uncertainty Reigns
A new US administration, China’s AI upset, and now a looming trade war have played havoc with the stock market...
Ohio’s Recreational Cannabis Market Sees Price Compression Amid New Efforts to Roll Back Laws
Just five months after launching, Ohio's adult-use cannabis market has reached $242.2 million in sales, largely in line with industry...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags